表紙:歯科感染症治療の市場規模・シェア・成長分析 (治療の種類別、感染症の種類別、エンドユーザー別、地域別):産業予測 (2025~2032年)
市場調査レポート
商品コード
1796120

歯科感染症治療の市場規模・シェア・成長分析 (治療の種類別、感染症の種類別、エンドユーザー別、地域別):産業予測 (2025~2032年)

Dental Infection Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Antibiotics, Antifungals), By Infection Type (Periodontal Infections, Endodontic Infections), By End-Users, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 184 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.16円
歯科感染症治療の市場規模・シェア・成長分析 (治療の種類別、感染症の種類別、エンドユーザー別、地域別):産業予測 (2025~2032年)
出版日: 2025年08月13日
発行: SkyQuest
ページ情報: 英文 184 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の歯科感染症治療の市場規模は、2023年に124億8,000万米ドルと評価され、2024年には136億4,000万米ドル、2032年には277億8,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは9.30%で成長する見込みです。

世界の歯科感染症治療市場は、主に歯周炎、う蝕、歯内感染などの歯科疾患の有病率の増加によって顕著な成長を遂げています。口腔衛生に対する意識の高まりと、歯の問題を抱えやすい高齢化層が、効果的な治療オプションに対する需要を煽っています。低侵襲処置や革新的な抗菌戦略を含む診断・治療手法の技術進歩が、この成長をさらに後押ししています。しかし、高度な治療に伴う高額な費用、発展途上地域での限られたアクセス性、不十分な歯科保険適用などが課題として残っています。さらに、病原体間の抗菌剤耐性の増加は、治療における継続的な技術革新を必要とします。患者の診断とモニタリングにおけるAIとIoTの統合は、この市場において早期発見を改善し、患者のケアを強化する機会を提示します。

目次

イントロダクション

  • 分析目的
  • 市場範囲
  • 定義

分析手法

  • 情報調達
  • 二次・一次データの手法
  • 市場規模予測
  • 市場の想定と制約

エグゼクティブサマリー

  • 市場の概要と展望
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析

市場の主な考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場魅力度指数 (2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術進歩
  • ケーススタディ
  • 顧客と購買基準の分析

世界の歯科感染症治療の市場規模・CAGR:治療の種類別 (2025~2032年)

  • 市場概要
  • 抗生物質
  • 抗真菌薬
  • 抗ウイルス薬
  • 疼痛管理
  • 外科処置(根管治療、抜歯)
  • 外用薬

世界の歯科感染症治療の市場規模・CAGR:感染症の種類別 (2025~2032年)

  • 市場概要
  • 歯周感染症(歯肉炎、歯周炎)
  • 歯内感染症(歯髄炎、膿瘍)
  • 虫歯関連感染症
  • 歯冠周囲炎
  • 口腔カンジダ症

世界の歯科感染症治療の市場規模・CAGR:エンドユーザー別 (2025~2032年)

  • 市場概要
  • 歯科医院
  • 病院
  • 外来手術センター
  • 研究・学術機関

世界の歯科感染症治療の市場規模・CAGR (2025~2032年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング (2024年)
  • 主要企業が採用した戦略
  • 市場の近年の動向
  • 主要企業の市場シェア (2024年)
  • 主要企業のプロファイル
    • 企業概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較 (2022~2024年)

主要企業プロファイル

  • Patterson Dental Supply, Inc.(米国)
  • Johnson & Johnson(米国)
  • Pfizer Inc.(米国)
  • Kerr Corporation(米国)
  • Bristol-Myers Squibb(米国)
  • Septodont Healthcare India Pvt. Ltd.(インド)
  • Henry Schein, Inc.(米国)
  • Ultradent Products Inc.(米国)
  • Endo Pharmaceuticals(米国)
  • Taj Pharmaceuticals Limited(インド)
  • Daiichi Sankyo(日本)
  • Bayer HealthCare(ドイツ)
  • Young Innovations, Inc.(米国)
  • 3M(米国)
  • A-dec Inc.(米国)
  • Dentsply Sirona Inc.(米国)
  • COLTENE Group(スイス)
  • Getinge AB(スウェーデン)
  • GC America Inc.(米国)

結論と提言

目次
Product Code: SQMIG35D2342

Global Dental Infection Treatment Market size was valued at USD 12.48 Billion in 2023 poised to grow between USD 13.64 Billion in 2024 to USD 27.78 Billion by 2032, growing at a CAGR of 9.30% in the forecast period (2025-2032).

The global dental infection treatment market is experiencing notable growth driven primarily by the increasing prevalence of dental diseases such as periodontitis, caries, and endodontic infections. Heightened awareness of oral hygiene, along with an aging demographic prone to dental issues, fuels demand for effective treatment options. Technological advancements in diagnostics and treatment methodologies, including minimally invasive procedures and innovative antimicrobial strategies, further bolster this growth. However, challenges persist due to the high costs associated with advanced treatments, limited accessibility in developing regions, and inadequate dental insurance coverage. Additionally, rising antimicrobial resistance among pathogens necessitates ongoing innovations in treatment. The integration of AI and IoT in patient diagnostics and monitoring presents opportunities for improving early detection and enhancing patient care in this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dental Infection Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dental Infection Treatment Market Segments Analysis

The global dental infection treatment market is segmented based on treatment type, infection type, end-user, and region. In terms of treatment type, the market is divided into antibiotics, antifungals, antivirals, pain management, surgical procedures, and topical medications. Based on infection type, the market is bifurcated into periodontal infections, endodontic infections, caries-related infections, pericoronitis, and oral candidiasis. Based on end-user, the market is grouped into dental clinics, hospitals, ambulatory surgical centres, and research & academic institutions. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Dental Infection Treatment Market

One key market driver for the global dental infection treatment market is the rising prevalence of dental diseases and infections, largely attributed to poor oral hygiene, unhealthy dietary habits, and a lack of awareness about dental care. As more individuals experience conditions such as periodontitis, dental abscesses, and endodontic infections, the demand for effective treatment options increases. This growing incidence of dental infections not only necessitates advancements in treatment technologies and pharmaceuticals but also fosters a greater emphasis on preventive care and public awareness campaigns, thus propelling the overall market for dental infection treatment solutions worldwide.

Restraints in the Global Dental Infection Treatment Market

One significant market restraint for the global dental infection treatment market is the rising prevalence of antibiotic resistance. As more bacteria develop resistance to commonly used antibiotics, the effectiveness of traditional treatments is compromised, leading to challenges in managing dental infections. This growing issue not only affects patient outcomes but also complicates treatment protocols for dental professionals. Additionally, the increasing awareness and caution among healthcare providers regarding the over-prescription of antibiotics may limit the adoption of necessary medical interventions. Consequently, the need for alternative treatment options and effective infection control measures becomes paramount, impacting the market's growth potential.

Market Trends of the Global Dental Infection Treatment Market

The global dental infection treatment market is experiencing a significant transformation driven by the integration of digital dentistry and AI-powered diagnostic solutions. These advancements facilitate enhanced imaging capabilities and streamline diagnostic processes, enabling clinicians to identify and address infections more promptly and effectively. As a result, personalized treatment plans are emerging, tailored to individual patient needs, which improves both diagnostic accuracy and overall health outcomes. Furthermore, the adoption of these innovative technologies enhances clinical workflows, fosters greater efficiency in dental practices, and sets the stage for ongoing innovations, underscoring a dynamic shift in how dental infections are diagnosed and treated worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Dental Infection Treatment Market Size by Treatment Type & CAGR (2025-2032)

  • Market Overview
  • Antibiotics
  • Antifungals
  • Antivirals
  • Pain Management
  • Surgical Procedures (Root Canal, Extraction)
  • Topical Medications

Global Dental Infection Treatment Market Size by Infection Type & CAGR (2025-2032)

  • Market Overview
  • Periodontal Infections (Gingivitis, Periodontitis)
  • Endodontic Infections (Pulpitis, Abscesses)
  • Caries-Related Infections
  • Pericoronitis
  • Oral Candidiasis

Global Dental Infection Treatment Market Size by End Users & CAGR (2025-2032)

  • Market Overview
  • Dental Clinics
  • Hospitals
  • Ambulatory Surgical Centres
  • Research & Academic Institutions

Global Dental Infection Treatment Market Size & CAGR (2025-2032)

  • North America (Treatment Type, Infection Type, End Users)
    • US
    • Canada
  • Europe (Treatment Type, Infection Type, End Users)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Infection Type, End Users)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Infection Type, End Users)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Infection Type, End Users)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Patterson Dental Supply, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerr Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Septodont Healthcare India Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Henry Schein, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ultradent Products Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endo Pharmaceuticals (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Taj Pharmaceuticals Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Daiichi Sankyo (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer HealthCare (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Young Innovations, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • A-dec Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dentsply Sirona Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • COLTENE Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GC America Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations